Keywords: bevacizumab intravitreal; Tumor vasoproliferativo; Bevacizumab intravÃtreo; Implante de dexametasona; Tocilizumab; Crioterapia; Vasoproliferative tumour; Intravitreal bevacizumab; Dexamethasone implant; Tocilizumab; Cryotherapy;
مقالات ISI bevacizumab intravitreal (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: bevacizumab intravitreal; Intravitreal bevacizumab; Phacoemulsification; Postoperative macular edema;
Keywords: bevacizumab intravitreal; Silicone oil droplets; Intravitreal bevacizumab; Vitreous;
Keywords: bevacizumab intravitreal; HIPAA; Health Insurance Portability and Accountability Act; IVB; intravitreal bevacizumab; IVT; intravitreal triamcinolone; logMAR; logarithm of the minimum angle of resolution; NLP; no light perception; SD; standard deviation; TRD; tractional retinal det
Keywords: bevacizumab intravitreal; AV; arteriovenous; BCVA; best-corrected visual acuity; BRAVO; RanibizumaB for the treatment of macular edema following bRAnch retinal Vein Occlusion; BRVO; branch retinal vein occlusion; BVOS; Branch Vein Occlusion Study; CFT; central foveal thickness; CP
Keywords: bevacizumab intravitreal; combination therapy; intravitreal bevacizumab; photodynamic therapy; polypoidal choroidal vasculopathy; reduced-fluence photodynamic therapy
Keywords: bevacizumab intravitreal; Coats disease; type 1 idiopathic macular telangiectasia; intravitreal bevacizumab; Leber multiple miliary aneurysms; retinal vascular disease
Supplemental Laser for Eyes Treated with Bevacizumab Monotherapy in Severe Retinopathy of Prematurity
Keywords: bevacizumab intravitreal; APROP; aggressive posterior retinopathy of prematurity; IVB; intravitreal bevacizumab; PMA; postmenstrual age; ROP; retinopathy of prematurity; VEGF; vascular endothelial growth factor;
Analysis of the Recurrence of Plus Disease after Intravitreal Ranibizumab as a Primary Monotherapy for Severe Retinopathy of Prematurity
Keywords: bevacizumab intravitreal; AP; aggressive posterior; BW; birth weight; GA; gestational age; IVB; intravitreal bevacizumab; PMA; postmenstrual age; ROP; retinopathy of prematurity; VEGF; vascular endothelial growth factor;
Favorable outcomes of adequate laser photocoagulation and salvage bevacizumab treatment for aggressive posterior retinopathy of prematurity
Keywords: bevacizumab intravitreal; Aggressive posterior retinopathy of prematurity; Laser treatment; Intravitreal bevacizumab;
Comparison of Intravitreal Bevacizumab and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity
Keywords: bevacizumab intravitreal; BEAT-ROP; Bevacizumab Eliminates the Angiogenic Threat of Retinopathy of Prematurity; CRYO-ROP; The Multicenter Trial of Cryotherapy for Retinopathy of Prematurity Study; D; diopter; IVB; intravitreal bevacizumab; RLP; retinal laser photocoagulation; ROP;
Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings
Keywords: bevacizumab intravitreal; BIO; binocular indirect ophthalmoscopy; ETROP; Early Treatment for Retinopathy of Prematurity; FA; fluorescein angiography; IVB; intravitreal bevacizumab; ROP; retinopathy of prematurity; VEGF; vascular endothelial growth factor;
Bevacizumab before Diabetic Vitrectomy
Keywords: bevacizumab intravitreal; BCVA; best-corrected visual acuity; DME; diabetic macular edema; IOL; intraocular lens; IOP; intraocular pressure; IVB; intravitreal bevacizumab; logMAR; logarithm of the minimum angle of resolution; NVG; neovascular glacouma; PDR; proliferative diabetic
One-Year Results of a Trial Comparing 2 Doses of Intravitreal Ziv-aflibercept versus Bevacizumab for Treatment of Diabetic Macular Edema
Keywords: bevacizumab intravitreal; BCVA; best-corrected visual acuity; CI; confidence interval; CMT; central macular thickness; DME; diabetic macular edema; ETDRS; Early Treatment Diabetic Retinopathy Study; IVB; intravitreal bevacizumab; IVZ; intravitreal ziv-aflibercept; logMAR; logarith
Traitement par bévacizumab et évolution des néovaisseaux choroïdiens compliquant les stries angioïdes : expérience du service d'ophtalmologie du CHU Hassan II
Keywords: bevacizumab intravitreal; Stries angioïdes; Néovascularisation choroïdienne; IVT de bévacizumab; Angioid streaks; Choroidal neovascularization; Intravitreal bevacizumab;
Two Doses of Intravitreal Ziv-Aflibercept versus Bevacizumab in Treatment of Diabetic Macular Edema: A Three-Armed, Double-Blind Randomized Trial
Keywords: bevacizumab intravitreal; BCVA; best-corrected visual acuity; CMT; central macular thickness; DME; diabetic macular edema; ERG; electroretinography; IVB; intravitreal bevacizumab; IVZ; intravitreal ziv-aflibercept; logMAR; logarithm of the minimum angle of resolution; OCT; optical
Cost Evaluation of Panretinal Photocoagulation versus Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy
Keywords: bevacizumab intravitreal; CMS; Centers for Medicare and Medicaid Services; CPT; Current Procedural Terminology; DME; diabetic macular edema; DRCR; Diabetic Retinopathy Clinical Research; DRS; Diabetic Retinopathy Study; IVB; intravitreal bevacizumab; IVR; intravitreal ranibizumab;
Clinical Management of Recurrent Retinopathy of Prematurity after Intravitreal Bevacizumab Monotherapy
Keywords: bevacizumab intravitreal; AA; adjusted age; APROP; aggressive posterior retinopathy of prematurity; BEAT-ROP; Bevacizumab Eliminates Angiogenic Threat of Retinopathy of Prematurity; BW; birth weight; CI; 95% confidence interval; DD; disc diameter; EFP; extraretinal fibrovascular p
Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity
Keywords: bevacizumab intravitreal; BEAT-ROP; Bevacizumab eliminates the Angiogenic Threat of Retinopathy of Prematurity; D; diopters; IOP; intraocular pressure; IVB; intravitreal bevacizumab; PRP; panretinal photocoagulation; ROP; retinopathy of prematurity;
Therapies for Macular Edema Associated with Central Retinal Vein Occlusion
Keywords: bevacizumab intravitreal; BCVA; best-corrected visual acuity; BRVO; branch retinal vein occlusion; CFT; central foveal thickness; COPERNICUS; Vascular Endothelial Growth Factor [VEGF] Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion [CRVO]; CRUISE;
Membrana neovascular subretiniana asociada a estrías angioides tratada con bevacizumab intravítreo
Keywords: bevacizumab intravitreal; Estrías angioides; Pseudoxantoma elástico; Membrana neovascular subretiniana; Anti-VEGF; Bevacizumab intravítreoAngioid streaks; Pseudoxanthoma elasticum; Neovascular subretinal membrane; Anti-VEGF; Intravitreal bevacizumab
Bevacizumab treatment for choroidal neovascularization in a patient with chorioretinopathy resembling presumed ocular histoplasmosis syndrome
Keywords: bevacizumab intravitreal; choroidal neovascularization; intravitreal bevacizumab; presumed ocular histoplasmosis syndrome
Intravitreal bevacizumab increases intraocular interleukin-6 levels at 1Â day after injection in patients with proliferative diabetic retinopathy
Keywords: bevacizumab intravitreal; Interleukin-6; Interleukin-8; Intravitreal bevacizumab; Proliferative diabetic retinopathy; Transforming growth factor-beta;
Cambios inmediatos en la presión intraocular después de una inyección intravÃtrea de 2,5Â mg de bevacizumab
Keywords: bevacizumab intravitreal; Bevacizumab intravÃtreo; Presión intraocular; Intravitreal bevacizumab; Intraocular pressure;